Logo image of EVOP

EVO PAYMENTS INC-CLASS A (EVOP) Stock Fundamental Analysis

NASDAQ:EVOP - Nasdaq - US26927E1047 - Common Stock - Currency: USD

33.99  +0.13 (+0.38%)

After market: 33.98 -0.01 (-0.03%)

Fundamental Rating

3

Taking everything into account, EVOP scores 3 out of 10 in our fundamental rating. EVOP was compared to 101 industry peers in the Financial Services industry. There are concerns on the financial health of EVOP while its profitability can be described as average. EVOP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

EVOP had negative earnings in the past year.
In the past year EVOP had a positive cash flow from operations.
In the past 5 years EVOP always reported negative net income.
Each year in the past 5 years EVOP had a positive operating cash flow.
EVOP Yearly Net Income VS EBIT VS OCF VS FCFEVOP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M 150M 200M

1.2 Ratios

The profitability ratios for EVOP are negative, so there is not much use analyzing them.
Looking at the Return On Invested Capital, with a value of 3.67%, EVOP is in the better half of the industry, outperforming 65.63% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EVOP is significantly above the industry average of 7.71%.
The 3 year average ROIC (23.91%) for EVOP is well above the current ROIC(3.67%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 3.67%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)23.91%
ROIC(5y)N/A
EVOP Yearly ROA, ROE, ROICEVOP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 -20 30

1.3 Margins

EVOP's Operating Margin of 12.33% is fine compared to the rest of the industry. EVOP outperforms 61.46% of its industry peers.
EVOP's Operating Margin has improved in the last couple of years.
EVOP's Gross Margin of 83.54% is amongst the best of the industry. EVOP outperforms 94.79% of its industry peers.
EVOP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.33%
PM (TTM) N/A
GM 83.54%
OM growth 3Y26.78%
OM growth 5Y6.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.39%
GM growth 5Y4.38%
EVOP Yearly Profit, Operating, Gross MarginsEVOP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

EVOP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, EVOP has more shares outstanding
EVOP has a better debt/assets ratio than last year.
EVOP Yearly Shares OutstandingEVOP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
EVOP Yearly Total Debt VS Total AssetsEVOP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

EVOP has an Altman-Z score of 0.14. This is a bad value and indicates that EVOP is not financially healthy and even has some risk of bankruptcy.
EVOP has a Altman-Z score of 0.14. This is in the lower half of the industry: EVOP underperforms 62.50% of its industry peers.
EVOP has a debt to FCF ratio of 6.22. This is a slightly negative value and a sign of low solvency as EVOP would need 6.22 years to pay back of all of its debts.
With a Debt to FCF ratio value of 6.22, EVOP perfoms like the industry average, outperforming 54.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.22
Altman-Z 0.14
ROIC/WACC0.5
WACC7.27%
EVOP Yearly LT Debt VS Equity VS FCFEVOP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M -500M

2.3 Liquidity

EVOP has a Current Ratio of 1.11. This is a normal value and indicates that EVOP is financially healthy and should not expect problems in meeting its short term obligations.
EVOP has a Current ratio of 1.11. This is comparable to the rest of the industry: EVOP outperforms 43.75% of its industry peers.
EVOP has a Quick Ratio of 1.10. This is a normal value and indicates that EVOP is financially healthy and should not expect problems in meeting its short term obligations.
EVOP has a Quick ratio (1.10) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.1
EVOP Yearly Current Assets VS Current LiabilitesEVOP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for EVOP have decreased strongly by -289.17% in the last year.
EVOP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.35%.
The Revenue has been growing slightly by 1.47% on average over the past years.
EPS 1Y (TTM)-289.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-442.51%
Revenue 1Y (TTM)9.35%
Revenue growth 3Y3.79%
Revenue growth 5Y1.47%
Sales Q2Q%4.98%

3.2 Future

EVOP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.23% yearly.
EVOP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.43% yearly.
EPS Next Y11.11%
EPS Next 2Y13.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.83%
Revenue Next 2Y12.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EVOP Yearly Revenue VS EstimatesEVOP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EVOP Yearly EPS VS EstimatesEVOP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

EVOP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 25.63, the valuation of EVOP can be described as expensive.
EVOP's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of EVOP to the average of the S&P500 Index (22.70), we can say EVOP is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 25.63
EVOP Price Earnings VS Forward Price EarningsEVOP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EVOP is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EVOP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 15.94
EV/EBITDA 12.75
EVOP Per share dataEVOP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20 -30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EVOP does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as EVOP's earnings are expected to grow with 13.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.23%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVOP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVO PAYMENTS INC-CLASS A

NASDAQ:EVOP (3/23/2023, 8:00:02 PM)

After market: 33.98 -0.01 (-0.03%)

33.99

+0.13 (+0.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-23 2023-02-23
Earnings (Next)05-02 2023-05-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.62%
Ins Owner Change0%
Market Cap1.65B
Analysts43.33
Price Target34.68 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.16%
Min EPS beat(2)6.16%
Max EPS beat(2)6.16%
EPS beat(4)3
Avg EPS beat(4)9.16%
Min EPS beat(4)6.16%
Max EPS beat(4)12.28%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.42%
Min Revenue beat(2)-7.71%
Max Revenue beat(2)-7.13%
Revenue beat(4)1
Avg Revenue beat(4)-3.95%
Min Revenue beat(4)-7.71%
Max Revenue beat(4)1.34%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.63
P/S 3.03
P/FCF 15.94
P/OCF 10.09
P/B N/A
P/tB N/A
EV/EBITDA 12.75
EPS(TTM)-0.11
EYN/A
EPS(NY)1.33
Fwd EY3.9%
FCF(TTM)2.13
FCFY6.27%
OCF(TTM)3.37
OCFY9.91%
SpS11.21
BVpS-15.73
TBVpS-34.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 3.67%
ROICexc 4.87%
ROICexgc 30.94%
OM 12.33%
PM (TTM) N/A
GM 83.54%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)23.91%
ROIC(5y)N/A
ROICexc(3y)4.71%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y31.27%
ROICexcg growth 5YN/A
ROICexc growth 3Y19.13%
ROICexc growth 5Y-5.52%
OM growth 3Y26.78%
OM growth 5Y6.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.39%
GM growth 5Y4.38%
F-Score3
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.22
Debt/EBITDA 4.25
Cap/Depr 71.1%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.1
Altman-Z 0.14
F-Score3
WACC7.27%
ROIC/WACC0.5
Cap/Depr(3y)56.66%
Cap/Depr(5y)59.66%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-289.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-442.51%
EPS Next Y11.11%
EPS Next 2Y13.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.35%
Revenue growth 3Y3.79%
Revenue growth 5Y1.47%
Sales Q2Q%4.98%
Revenue Next Year12.83%
Revenue Next 2Y12.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.13%
EBIT growth 3Y31.58%
EBIT growth 5Y8.18%
EBIT Next Year161.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y116.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.41%
OCF growth 3Y80.13%
OCF growth 5Y81.85%